<p>The most common treatment-emergent adverse events are nausea and vomiting which generally occurre during the first 1-2 days of therapy.<br />
<br />
The following drug-related adverse events are reported infrequently in patients receiving Tigecycline: Injection site inflammation &amp; pain, septic shock, allergic reaction, chills, thrombophlebitis, bradycardia, tachycardia, vasodilatation, anorexia, dry mouth, hypoglycemia, hyponatremia, prolonged prothrombin time, eosinophilia, thrombocytopenia, vaginal moniliasis, vaginitis, leukorrhea.</p>